The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.... Research Beam Model: Research Beam Product ID: 20791 1200 USD New
Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
 
 

Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

  • Category : Diagnostic and Biotech
  • Published On : July   2014
  • Pages : 407
  • Publisher : VPGMarketResearch.com
 
 
 

Complete report $1,850.  DataPack (test volumes, sales forecasts, supplier shares) $1,200.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. 



This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testig for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. 



Report Highlights



- Market shares of leading suppliers

- Business and technological trends in major markets

- Five-year test volume and sales forecasts

- Market shares of leading competitors

- Feature comparison of major analyzers

- Strategic profiles of leading market players and start-up firms developing innovative products

- Specific product and business opportunities for instrument and consumable suppliers.



Rationale



Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.  In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.



Germany Market Overview



- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.



- Five-year test volume and sales projections.



Market Segmentation Analysis



- Five-year test volume and sales projections:



- Infectious Diseases        - Forensic Testing

- Cancer                            - Paternity Testing/HLA Typing

- Genetic Diseases            - Others



- A comprehensive analysis of the sequencing market by laboratory segment.

  

- Detailed market segmentation analysis, including review of the market dynamics, trends,

  structure, size, growth and major suppliers.



Product/Technology Review



- Comparison of the major molecular diagnostic analyzers.



- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,

  trends in testing automation and over target/signal amplification methods.



- Worldwide listings of companies, universities and research centers developing new molecular

   diagnostic technologies and products.



Competitive Assessments



- Extensive strategic assessments of major suppliers and emerging market entrants,

  including their sales, product portfolios, marketing tactics, collaborative arrangements and

  new technologies/products in R&D.

  

   - Abbott

   - Affymetrix

   - Agilent Technologies

   - Applied Gene Technologies

   - Arca/Nuvelo

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biokit

   - BioMerieux

   - Bio-Rad

   - Biotest

   - Caliper

   - Cepheid

   - Decode

   - Diadexus

   - Eiken

   - Enzo

   - Exact Sciences

   - Fujirebio/Innogenetics

   - Grifols

   - Hologic/Gen-Probe

   - Illumina

   - Kreatech

   - Li-Cor Biosciences

   - Life Technologies/Thermo Fisher

   - Monogram Biosciences

   - Myriad Genetics

   - Nanogen/Elitech

   - Orchid CellMark

   - Ortho-Clinical Diagnostics

   - Proteome Sciences

   - Qiagen              

   - Roche

   - Scienion

   - Sequenom

   - Shimadzu

   - Siemens

   - Sierra Molecular

   - Takara Bio

   - Tecan Group



- Comprehensive listings of companies developing and marketing molecular

  diagnostic products, by test and application.



Opportunities and Strategic Recommendations



- Specific new product development opportunities with potentially significant market appeal

  during the next five years.



- Design criteria for new products.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.



- Business planning issues and concerns.



Contains 407 pages


I. Outlook

Introduction

Industry Consolidation and Diversification: A Biomodal Trend

Market Globalization

Pricing Pressures

Productivity

II. Major Geographic Regions

North America

Europe

Japan

Latin AmericaIntroduction

Global Market Trends and Emerging Technologies

A. DNA Sequencing

B. DNA and RNA Probe Technology

C. Detection Technologies

D. Instrumentation: Review of Automated and Semi-Automated Analyzers


E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip

F. Pharmacogenomics

G. Cancer Molecular Diagnostics Testing

1. Overview

2. Major Cancer Types

3. Oncogenes

H. Genetic Diseases Molecular Diagnostic Testing

1. Overview

2. Nucleic Acid Amplification

3. Chromosome Imaging

4. Genomics Technologies

5. Proteomics Technologies

6. Current Pharmacogenomic Testing

7. Major Diseases

I. Forensic Molecular Diagnostics Testing

1. Overview

2. Multilocus and Single Locus Probes

3. The FBI

Table of Contents (continued)

4. DNA Profile Data Banks

5. Judicial Implementation

6. Major Crime Categories

7. Factors Contributing to the DNA Probe

Major Expansion

J. Paternity Testing/HLA Typing Molecular Diagnostic Testing

K. Other Molecular Diagnostic Testing Applications

L. Competing/Complementing Technologies

Germany


A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Dynamics, Trends, Size and Growth

- Volume Forecasts by Market Segment

- Sales Forecasts by Market Segment

- Major Supplier Sales and Market Shares

Major Product Development Opportunities

A. Opportunities for New Instrumentation

B. Opportunities for New Reagent Kits and Test Systems/Panels

C. Opportunities for New IT, Computers, Software and Automation

D. Opportunities for New Auxiliary Products

Design Criteria For Decentralized Testing Products


Alternative Market Penetration Strategies

Potential Market Entry Barriers And Risks

Competitive Profiles

- Abbott

- Affymetrix

- Agilent Technologies

- Applied Gene Technologies

Table of Contents (continued)

- Arca/Nuvelo

- Beckman Coulter/Danaher

- Becton Dickinson

- Biokit

- BioMerieux

- Bio-Rad

- Biotest

- Caliper

- Cepheid

- Decode

- Diadexus

- Eiken

- Enzo

- Exact Sciences

- Fujirebio/Innogenetics

- Grifols

- Hologic/Gen-Probe

- Illumina

- Kreatech

- Li-Cor Biosciences

- Life Technologies/Thermo Fisher

- Monogram Biosciences

- Myriad Genetics

- Nanogen/Elitech

- Orchid CellMark

- Ortho-Clinical Diagnostics

- Proteome Sciences

- Qiagen

- Roche

- Scienion

- Sequenom

- Shimadzu

- Siemens

- Sierra Molecular

- Takara Bio

- Tecan Group

Appendixes

List of Tables

Oncogenes Potential Applications in Cancer Diagnosis

Major Companies Developing or Marketing Cancer

Molecular Diagnostic Tests

Major Companies Developing or Marketing Molecular Diagnostic Tests

For Genetic Diseases

Germany, Laboratories Performing

DNA Sequencing by Market Segment

Germany, Molecular Diagnostics Market

Potential Laboratory Universe by Market Segment

Germany, Molecular Diagnostic Test Volume Forecast

By Major Application

Germany, Molecular Diagnostic Market Forecast

By Major Application

Germany, Molecular Diagnostics

Market by Major Supplier

III. Major Modalities

X-Ray

Ultrasound

MRI

CT

Nuclear Medicine

PET

PACS

IV. Market Size and Growth

V. Strategic Directions


Business, new product development, and marketing strategies

Anticipated acquisitions, joint ventures, and divestitures

VI. Marketing Tactics

The U.S. and international sales force size in major geographic regions

Selling options, including rental plans, leasing and others

Promotional tactics, e.g., pricing, discounts, advertising, trade shows,

seminars, product literature, newsletters, etc

System service and support

VII. Technological Know-How

Internally developed and acquired diagnostic imaging and related

technologies, Including X-ray, ultrasound, MRI, CT, nuclear medicine, PET,

PACS, and others.

List of Tables

Table 1: Worldwide Diagnostic Imaging Market

Estimated Sales by Geographic Region and Country

Table 2: Worldwide Diagnostic Imaging Market

Estimated Sales Growth by Geographic Region and Country

Table 3: Worldwide Diagnostic Imaging Market

Estimated Sales by Modality and Business

Table 4: Worldwide Diagnostic Imaging Market

Estimated Sales by Modality/Business

And Geographic Region

Table 5: Worldwide Diagnostic Imaging Market

Estimated Sales Growth by Modality/Busine


PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT